@article{9e3f3dc0339846b9b40794dadccb9302,
title = "National Trends in Management of Pathologic Stage III Melanoma",
author = "Rhodin, {Kristen E.} and Farrow, {Norma E.} and Maria Xu and Jay Lee and Tyler, {Douglas S.} and Beasley, {Georgia M.}",
note = "Funding Information: Georgia Beasley has received clinical trial funding paid to Duke University from Delcath, Istari, Replimune, Oncosec, and Checkmate, and has served on a one-time advisory board for Cardinal Health and Regeneron. She is also supported by NIH K08 CA237726-01A1. Kristen E. Rhodin is supported by NIH 1R38AI140297. Norma E. Farrow, Maria Xu, Jay Lee, and Douglas S. Tyler have no disclosures to declare. Funding Information: The NCDB is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC{\textquoteright}s NCDB and the hospitals participating in the NCDB are the source of the de-identified data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.",
year = "2023",
month = may,
doi = "10.1245/s10434-023-13101-6",
language = "English (US)",
volume = "30",
pages = "2586--2589",
journal = "Annals of surgical oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "5",
}